The advent of precision medicine has brought light to the treatment of non-small cell lung
cancer (NSCLC), expanding the options for patients with advanced NSCLC by targeting …

Tyrosine kinase receptors (TKR) comprise more than 60 molecules that play an essential
role in the molecular pathways, leading to cell survival and differentiation. Consequently …

Lung cancer causes significant morbidity and mortality in China and worldwide. In China,
lung cancer accounts for nearly one-fourth of all cancer deaths. Non-small cell lung cancer …

Molecular characterization of tumors has shifted cancer treatment strategies away from
nonspecific cytotoxic treatment of histology-specific tumors toward targeting of actionable …

While new targeted therapies have considerably changed the treatment and prognosis of
non-small cell lung cancer (NSCLC), they are frequently unsuccessful due to primary or …

Non-small cell lung cancer (NSCLC) is the most common type of lung cancer accounting for
almost 80%–85% of all lung cancer cases. Unfortunately, more than half of the patients will …

Simple Summary Alterations in cholesterol level play an important role in cancer
development. Lipid transfer proteins (LTPs) are involved in cholesterol distribution between …

Background The proto‐oncogene ROS1 encodes an intrinsic type I membrane protein of the
tyrosine kinase/insulin receptor family. ROS1 facilitates the progression of various …

Background To systematically assess the consistency of recommendations regarding
diagnosis and treatment of non-small cell lung cancer (NSCLC) in clinical practice …

Immunotherapy, a chemotherapy-free process, has emerged as a promising therapeutic
strategy to prolong the overall survival (OS) of patients with non-small-cell lung cancer …